-
-
-
-
-
-
-
Royalty Pharma and Zymeworks Enter Into $250 Million Royalty-Backed Note Financing
-
-
-
-
-
-
-
Zymeworks Announces Strategic Initiative to Optimize Value of Licensed Products by Building a Diversified Portfolio of Revenue-Generating Assets
-
-
-
-
-
100,843 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

